Impiricus Launches Digital Wallet to Support Physicians and Patients

In June 2024, Impiricus launched the Impiricus Wallet—a first-of-its-kind digital resource tool designed to make critical patient support accessible at the point of care. Delivered through our proprietary HCP network and stored in digital wallets, physicians can share co-pay, hub, clinical trial, or education resources directly with patients—no app required. “Physicians consistently tell us that […]

Impiricus Joins MM+M Podcast on the Future of Pharma Interactions

As part of our commitment to physician-first innovation, Impiricus Co-Founder Dr. Osama Hashmi joined MM+M’s Mark Iskowitz and physician Dr. Tamara Greene on a special podcast episode titled The Expected Evolution of Pharma Interactions. The conversation dives into how pharma can adapt to better meet the real-time needs of HCPs. Hear directly from physicians on […]

Life Sciences Veteran Brian Longo Joins Impiricus as Strategic Advisor

Impiricus is pleased to welcome Brian Longo as a strategic advisor. A pioneer in the life sciences software industry and former Veeva executive, Brian brings two decades of leadership experience scaling enterprise platforms. “Brian’s deep industry knowledge and proven track record will help accelerate our growth and innovation roadmap,” said Sandy Donaldson, CEO and Co-Founder. […]

Dr. Osama Hashmi to Speak at 2025 Medical Affairs Strategic Summit

We are thrilled to share that Dr. Osama Hashmi, Co-Founder and Head of Product at Impiricus, will speak at the 2025 Medical Affairs Strategic Summit (MASS East). Dr. Hashmi will offer his unique perspective as both a physician and product leader on how technology and real-world insights can power next-gen Medical Affairs strategy. This appearance […]

Impiricus Raises $3M in Seed Funding Led by FCA Venture Partners

In 2022, Impiricus closed a $3 million Series Seed financing round led by FCA Venture Partners, with participation from Surface Ventures. “Impiricus clearly fits our investment thesis,” said Todd Johnson, Partner at FCA Venture Partners. “A bold leadership team with a powerful product and the potential to reshape pharma-HCP collaboration.” The funding supports our ongoing […]